STAT

Opinion: Generative AI’s three possibly insurmountable challenges for health care

These are key elements of diagnostic decision-making, elements that ought not to be casually discarded.
Source: Adobe

Talk about AI in medicine often focuses on the most exiting possible innovations like precision diagnostics, clinical prediction systems, and analytics-driven drug discovery. and . And it’s obvious why. As a patient, I hate the experience of having to talk to my doctors as they peer at me just over the laptop screen (all the while typing furiously). It really takes the feeling of care out of health . And, of course, , probably more than patients do. There’s no end to the complaints about increasing documentation demands, poor interface design, and incessant alerts.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks